Summary
BIOTECH firm NovaBiotics has received clearance from the Federal Institute for Drugs and Medical Devices and the Ethics Commission to commence first-in-man clinical trials of its lead product.
NovaBiotics, which is based in Aberdeen, is to start trials of its fungal nail treatment Novexatin, in a move that will take the firm a step closer to commercialisation of the product.See the full content of this document
Extract
Novabiotics Gets Green Light for Human Drug Trial
Dr Deborah O'Neil, who found...
See the full content of this document
Sponsored links
